Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $0.7.

  • Strata Critical Medical's EPS (Basic) rose 110000.0% to $0.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.49, marking a year-over-year increase of 16621.62%. This contributed to the annual value of -$0.35 for FY2024, which is 5363.8% up from last year.
  • Per Strata Critical Medical's latest filing, its EPS (Basic) stood at $0.7 for Q3 2025, which was up 110000.0% from -$0.05 recorded in Q2 2025.
  • Strata Critical Medical's EPS (Basic)'s 5-year high stood at $0.7 during Q3 2025, with a 5-year trough of -$0.47 in Q2 2021.
  • Over the past 5 years, Strata Critical Medical's median EPS (Basic) value was -$0.14 (recorded in 2023), while the average stood at -$0.1.
  • In the last 5 years, Strata Critical Medical's EPS (Basic) tumbled by 529076.41% in 2021 and then soared by 110000.0% in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's EPS (Basic) stood at $0.01 in 2021, then crashed by 2263.87% to -$0.22 in 2022, then plummeted by 112.58% to -$0.46 in 2023, then soared by 47.89% to -$0.24 in 2024, then soared by 392.04% to $0.7 in 2025.
  • Its last three reported values are $0.7 in Q3 2025, -$0.05 for Q2 2025, and -$0.04 during Q1 2025.